secwatch / observer
8-K filed November 3, 2023, 7:59 PM ET ticker NDAQ CIK 0001120193
M&A confidence high sentiment positive materiality 0.85

NASDAQ, INC. (NDAQ): M&A transaction — Nasdaq completes $10.02B acquisition of Adenza from Thoma Bravo; appoints Holden Spaht to board

NASDAQ, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Holden Spaht

Director
NDAQ · NASDAQ, INC.
Effective
2023-11-01
Filed
November 3, 2023, 7:59 PM ET
On November 1, 2023, effective as of the closing of the Mergers, Mr. Spaht was appointed to the Board of Directors of Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Holden Spaht was appointed as Director at NASDAQ, INC..

Action
appointed
Role
Director
Exact text from the filing
On November 1, 2023, effective as of the closing of the Mergers, Mr. Spaht was appointed to the Board of Directors of Nasdaq.
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

NASDAQ, INC. completed an acquisition involving Adenza Holdings, Inc. for approximately $10.02 billion (closed 2023-11-01).

Action
acquisition
Counterparty
Adenza Holdings, Inc.
Consideration
approximately $10.02 billion
Closing
2023-11-01
Exact text from the filing
closing price of Nasdaq common stock on October 31, 2023, the Stock Consideration had a value of approximately $4.25 billion, for an aggregate transaction value of approximately $10.02 billion. The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by the full text of the Merger Agreement, a copy of which was
View on SEC.gov

Browse all m&a transactions →

NASDAQ, INC. filing history →

Source: SEC EDGAR
accession 0001193125-23-270374
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.